BCM
IBIO icon

Bridgeway Capital Management’s iBio IBIO Stock Holding History

Bridgeway Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,250
Closed -$52K – 1419
2023
Q1 		$52K Hold
1,250
– – ﹤0.01% 1309
2022
Q4 		$11.1K Buy
+1,250
New +$42.3K ﹤0.01% 1358
2022
Q1 		– Sell
-200
Closed -$55K – 1333
2021
Q4 		$55K Hold
200
– – ﹤0.01% 1241
2021
Q3 		$106K Hold
200
– – ﹤0.01% 1248
2021
Q2 		$151K Hold
200
– – ﹤0.01% 1284
2021
Q1 		$154K Buy
+200
New +$174K ﹤0.01% 1301

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Bridgeway Capital Management's IBIO Position: Q2 2023 in Review

Bridgeway Capital Management sold out of iBio (IBIO) in Q2 2023, closing a stake of 1,250 shares — an estimated $52K sold.

Bridgeway Capital Management first reported a position in IBIO in Q1 2021 and held it in 6 quarters. The position peaked at $154K in Q1 2021. 28 funds tracked by Wall St. Rank hold IBIO as of Q2 2023.

  • Bridgeway Capital Management reported no remaining iBio position as of Q2 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 1,250 iBio shares in Q2 2023, an estimated $52K.
  • Bridgeway Capital Management first reported a position in iBio in Q1 2021 and held it in 6 quarters.
  • Bridgeway Capital Management's iBio position peaked at $154K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held iBio as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.